Updated on 2024/08/26

Information

 

写真a

 
YAGI MIKAKO
 
Organization
Faculty of Medical Sciences Department of Health Sciences Assistant Professor
Kyushu University Hospital Clinical Laboratories(Joint Appointment)
School of Medicine Department of Health Sciences(Joint Appointment)
Title
Assistant Professor
Contact information
メールアドレス
Tel
0926426702

Research Interests・Research Keywords

  • Research theme:Elucidation of new molecular mechanisms of mitochondria-associated senescence diseases and ferotosis and their treatment

    Keyword:Mitochondria, Lysosome, Ferroptosis

    Research period: 2024.4 - 2026.3

  • Research theme:Functional analysis and preventive treatment of mitochondria-associated diseases that develop with aging

    Keyword:mitochondria Lysosome aging

    Research period: 2021.4 - 2023.3

  • Research theme:Mitochondria regulate autophagy and metabolites of aging-related diseases

    Keyword:motochondria autophagy

    Research period: 2018.4 - 2021.3

Papers

  • Improving lysosomal ferroptosis with NMN administration protects against heart failure Reviewed International journal

    Mikako Yagi, Yura Do, Haruka Hirai, Kenji Miki, Takahiro Toshima, Yukina Fukahori, Daiki Setoyama, Chiaki Abe, Yo Ichi Nabeshima, Dongchon Kang, Takeshi Uchiumi

    Life Science Alliance   6 ( 12 )   e202302116   2023.12

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)  

    DOI: doi.org/10.26508/lsa.202302116

  • Mitochondrial haplotype mutation alleviates respiratory defect of MELAS by restoring taurine modification in tRNA with 3243A > G mutation. Reviewed International journal

    Saori Ueda, Mikako Yagi, Ena Tomoda, Shinya Matsumoto, Yasushi Ueyanagi, Yura Do, Daiki Setoyama, Yuichi Matsushima, Asuteka Nagao, Tsutomu Suzuki, Tomomi Ide, Yusuke Mori, Noriko Oyama, Dongchon Kang, Takeshi Uchiumi

    Nucleic acids research   51 ( 14 )   7480 - 7495   2023.8   ISSN:0305-1048 eISSN:1362-4962

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)  

    The 3243A > G in mtDNA is a representative mutation in mitochondrial diseases. Mitochondrial protein synthesis is impaired due to decoding disorder caused by severe reduction of 5-taurinomethyluridine (τm5U) modification of the mutant mt-tRNALeu(UUR) bearing 3243A > G mutation. The 3243A > G heteroplasmy in peripheral blood reportedly decreases exponentially with age. Here, we found three cases with mild respiratory symptoms despite bearing high rate of 3243A > G mutation (>90%) in blood mtDNA. These patients had the 3290T > C haplotypic mutation in addition to 3243A > G pathogenic mutation in mt-tRNALeu(UUR) gene. We generated cybrid cells of these cases to examine the effects of the 3290T > C mutation on mitochondrial function and found that 3290T > C mutation improved mitochondrial translation, formation of respiratory chain complex, and oxygen consumption rate of pathogenic cells associated with 3243A > G mutation. We measured τm5U frequency of mt-tRNALeu(UUR) with 3243A > G mutation in the cybrids by a primer extension method assisted with chemical derivatization of τm5U, showing that hypomodification of τm5U was significantly restored by the 3290T > C haplotypic mutation. We concluded that the 3290T > C is a haplotypic mutation that suppresses respiratory deficiency of mitochondrial disease by restoring hypomodified τm5U in mt-tRNALeu(UUR) with 3243A > G mutation, implying a potential therapeutic measure for mitochondrial disease associated with pathogenic mutations in mt-tRNAs.

    DOI: 10.1093/nar/gkad591

    Web of Science

    Scopus

    PubMed

    researchmap

  • Mitochondrial haplotype mutation alleviates respiratory defect of MELAS by restoring taurine modification in tRNA with 3243A > G mutation Reviewed International journal

    #Saori Ueda, @Mikako Yagi, Ena Tomoda, Shinya Matsumoto, Yasushi Ueyanagi, Yura Do, @Daiki Setoyama, Yuichi Matsushima, Asuteka Nagao, Tsutomu Suzuki, @Tomomi Ide, Yusuke Mori, Noriko Oyama, @Dongchon Kang, @Takeshi Uchiumi

    Nucleic acids research   2023.7

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)  

    DOI: doi.org/10.1093/nar/gkad591

  • Induction of glioblastoma cell ferroptosis using combined treatment with chloramphenicol and 2-deoxy-d-glucose Invited Reviewed International journal

    Kenji Miki, Mikako Yagi, Naoki Noguchi, Yura Do, Ryosuke Otsuji, Daisuke Kuga, Dongchon Kang, Koji Yoshimoto & Takeshi Uchiumi

    Scientific Reports   2023.6

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)  

    DOI: doi.org/10.1038/s41598-023-37483-5

  • Mitochondrial dysfunction and impaired growth of glioblastoma cell lines caused by antimicrobial agents inducing ferroptosis under glucose starvation Invited Reviewed International journal

    Kenji Miki, Mikako Yagi, Koji Yoshimoto, Dongchon Kang, Takeshi Uchiumi

    ONCOGENESIS   11 ( 1 )   59   2022.10   ISSN:2157-9024

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/s41389-022-00437-z

    Web of Science

    Scopus

    PubMed

    researchmap

  • TFAM expression in brown adipocytes confers obesity resistance by secreting extracellular vesicles that promote self-activation Invited Reviewed International journal

    Masakazu Fujii, Daiki Setoyama, Kazuhito Gotoh, Yushi Dozono, Mikako Yagi, Masataka Ikeda, Tomomi Ide, Takeshi Uchiumi, Dongchon Kang

    iSCIENCE   25 ( 9 )   104889   2022.9   eISSN:2589-0042

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.isci.2022.104889

    Web of Science

    Scopus

    PubMed

    researchmap

  • Mitochondrial translation deficiency impairs NAD(+)-mediated lysosomal acidification Invited Reviewed International journal

    Mikako Yagi, Takahiro Toshima, Rie Amamoto, Yura Do, Haruka Hirai, Daiki Setoyama, Dongchon Kang, Takeshi Uchiumi

    EMBO JOURNAL   40 ( 8 )   2021.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.15252/embj.2020105268

  • Neural-specific deletion of mitochondrial p32/C1qbp leads to leukoencephalopathy due to undifferentiated oligodendrocyte and axon degeneration Reviewed

    Mikako Yagi, Takeshi Uchiumi, Noriaki Sagata, Daiki Setoyama, Rie Amamoto, Yuichi Matsushima, Dongchon Kang

    Scientific reports   7 ( 1 )   2017.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/s41598-017-15414-5

  • Cardiomyocyte-specific loss of mitochondrial p32/C1qbp causes cardiomyopathy and activates stress responses Reviewed

    Toshiro Saito, Takeshi Uchiumi, Mikako Yagi, Rie Amamoto, Daiki Setoyama, Yuichi Matsushima, Dongchon Kang

    Cardiovascular research   113 ( 10 )   1173 - 1185   2017.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1093/cvr/cvx095

  • p32/gC1qR is indispensable for fetal development and mitochondrial translation: importance of its RNA-binding ability Invited Reviewed International journal

    Mikako Yagi, Takeshi Uchiumi, Shinya Takazaki, Bungo Okuno, Masatoshi Nomura, Shin Ichi Yoshida, Tomotake Kanki, Dongchon Kang

    NUCLEIC ACIDS RESEARCH   40 ( 19 )   9717 - 9737   2012.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1093/nar/gks774

  • Mitochondrial p32/C1QBP is highly expressed in prostate cancer and is associated with shorter prostate-specific antigen relapse time after radical prostatectomy Invited Reviewed International journal

    Amamoto, R., Yagi, M., Song, Y. H., Oda, Y., Tsuneyoshi, M., Naito, S., Yokomizo, A., Kuroiwa, K., Tokunaga, S., Kato, S., Hiura, H., Samori, T., Kang, D. & Uchiumi, T.,

    CANCER SCIENCE   102 ( 3 )   639 - 647   2011.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/j.1349-7006.2010.01828.x

  • Molecular cloning, functional expression, and mutagenesis of cDNA encoding rye (Secale cereale) seed chitinase-c Invited Reviewed International journal

    Takayuki Ohnuma, Mikako Yagi, Takeshi Yamagami, Toki Taira, Yoichi Aso, Masatsune Ishiguro

    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY   66 ( 2 )   277 - 284   2002.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  • iMPAQT reveals that adequate mitohormesis from TFAM overexpression leads to life extension in mice

    Igami, K; Kittaka, H; Yagi, M; Gotoh, K; Matsushima, Y; Ide, T; Ikeda, M; Ueda, S; Nitta, SI; Hayakawa, M; Nakayama, KI; Matsumoto, M; Kang, D; Uchiumi, T

    LIFE SCIENCE ALLIANCE   7 ( 7 )   2024.7   eISSN:2575-1077

     More details

    Language:English   Publisher:Life Science Alliance  

    Mitochondrial transcription factor A, TFAM, is essential for mitochondrial function. We examined the effects of overexpressing the TFAM gene in mice. Two types of transgenic mice were created: TFAM heterozygous (TFAM Tg) and homozygous (TFAM Tg/Tg) mice. TFAM Tg/Tg mice were smaller and leaner notably with longer lifespans. In skeletal muscle, TFAM overexpression changed gene and protein expression in mitochondrial respiratory chain complexes, with down-regulation in complexes 1, 3, and 4 and up-regulation in complexes 2 and 5. The iMPAQT analysis combined with metabolomics was able to clearly separate the metabolomic features of the three types of mice, with increased degradation of fatty acids and branched-chain amino acids and decreased glycolysis in homozygotes. Consistent with these observations, comprehensive gene expression analysis revealed signs of mitochondrial stress, with elevation of genes associated with the integrated and mitochondrial stress responses, including Atf4, Fgf21, and Gdf15. These found that mitohormesis develops and metabolic shifts in skeletal muscle occur as an adaptive strategy.

    DOI: 10.26508/lsa.202302498

    Web of Science

    Scopus

    PubMed

  • Mitochondrial translation failure represses cholesterol gene expression via Pyk2-Gsk3β-Srebp2 axis

    Toshima, T; Yagi, M; Do, Y; Hirai, H; Kunisaki, Y; Kang, DC; Uchiumi, T

    LIFE SCIENCE ALLIANCE   7 ( 7 )   2024.7   eISSN:2575-1077

     More details

    Language:English   Publisher:Life Science Alliance  

    Neurodegenerative diseases and other age-related disorders are closely associated with mitochondrial dysfunction. We previously showed that mice with neuron-specific deficiency of mitochondrial translation exhibit leukoencephalopathy because of demyelination. Reduced cholesterol metabolism has been associated with demyelinating diseases of the brain such as Alzheimer’s disease. However, the molecular mechanisms involved and relevance to the pathogenesis remained unknown. In this study, we show that inhibition of mitochondrial translation significantly reduced expression of the cholesterol synthase genes and degraded their sterol-regulated transcription factor, sterol regulatory element-binding protein 2 (Srebp2). Further-more, the phosphorylation of Pyk2 and Gsk3β was increased in the white matter of p32cKO mice. We observed that Pyk2 inhibitors reduced the phosphorylation of Gsk3β and that GSK3β inhibitors suppressed degradation of the transcription factor Srebp2. The Pyk2–Gsk3β axis is involved in the ubiquitination of Srebp2 and reduced expression of cholesterol gene. These results suggest that inhibition of mitochondrial translation may be a causative mechanism of neurodegenerative diseases of aging. Improving the mitochondrial translation or effectiveness of Gsk3β inhibitors is a potential therapeutic strategy for leukoencephalopathy.

    DOI: 10.26508/lsa.202302423

    Web of Science

    Scopus

    PubMed

  • Glucose starvation causes ferroptosis-mediated lysosomal dysfunction

    Miki, K; Yagi, M; Kang, DC; Kunisaki, Y; Yoshimoto, K; Uchiumi, T

    ISCIENCE   27 ( 5 )   109735   2024.5   eISSN:2589-0042

     More details

    Language:English   Publisher:iScience  

    Lysosomes, the hub of metabolic signaling, are associated with various diseases and participate in autophagy by supplying nutrients to cells under nutrient starvation. However, their function and regulation under glucose starvation remain unclear and are studied herein. Under glucose starvation, lysosomal protein expression decreased, leading to the accumulation of damaged lysosomes. Subsequently, cell death occurred via ferroptosis and iron accumulation due to DMT1 degradation. GPX4, a key factor in ferroptosis inhibition located on the outer membrane of lysosomes, accumulated in lysosomes, especially under glucose starvation, to protect cells from ferroptosis. ALDOA, GAPDH, NAMPT, and PGK1 are also located on the outer membrane of lysosomes and participate in lysosomal function. These enzymes did not function effectively under glucose starvation, leading to lysosomal dysfunction and ferroptosis. These findings may facilitate the treatment of lysosomal-related diseases.

    DOI: 10.1016/j.isci.2024.109735

    Web of Science

    Scopus

    PubMed

  • Cardiomyocyte-specific deletion of the mitochondrial transporter Abcb10 causes cardiac dysfunction via lysosomal-mediated ferroptosis

    Do, Y; Yagi, M; Hirai, H; Miki, K; Fukahori, Y; Setoyama, D; Yamamoto, M; Furukawa, T; Kunisaki, Y; Kang, DC; Uchiumi, T

    BIOSCIENCE REPORTS   44 ( 5 )   2024.5   ISSN:0144-8463 eISSN:1573-4935

     More details

    Language:English   Publisher:Bioscience reports  

    Heart function is highly dependent on mitochondria, which not only produce energy but also regulate many cellular functions. Therefore, mitochondria are important therapeutic targets in heart failure. Abcb10 is a member of the ABC transporter superfamily located in the inner mitochondrial membrane and plays an important role in haemoglobin synthesis, biliverdin transport, antioxidant stress, and stabilization of the iron transporter mitoferrin-1. However, the mechanisms underlying the impairment of mitochondrial transporters in the heart remain poorly understood. Here, we generated mice with cardiomyocyte-specific loss of Abcb10. The Abcb10 knockouts exhibited progressive worsening of cardiac fibrosis, increased cardiovascular risk markers and mitochondrial structural abnormalities, suggesting that the pathology of heart failure is related to mitochondrial dysfunction. As the mitochondrial dysfunction was observed early but mildly, other factors were considered. We then observed increased Hif1α expression, decreased NAD synthase expression, and reduced NAD+ levels, leading to lysosomal dysfunction. Analysis of ABCB10 knockdown HeLa cells revealed accumulation of Fe2+ and lipid peroxides in lysosomes, leading to ferroptosis. Lipid peroxidation was suppressed by treatment with iron chelators, suggesting that lysosomal iron accumulation is involved in ferroptosis. We also observed that Abcb10 knockout cardiomyocytes exhibited increased ROS production, iron accumulation, and lysosomal hypertrophy. Our findings suggest that Abcb10 is required for the maintenance of cardiac function and reveal a novel pathophysiology of chronic heart failure related to lysosomal function and ferroptosis.

    DOI: 10.1042/BSR20231992

    Web of Science

    Scopus

    PubMed

  • Improving lysosomal ferroptosis with NMN administration protects against heart failure

    Yagi, M; Do, Y; Hirai, H; Miki, K; Toshima, T; Fukahori, Y; Setoyama, D; Abe, C; Nabeshima, YI; Kang, DC; Uchiumi, T

    LIFE SCIENCE ALLIANCE   6 ( 12 )   2023.12   eISSN:2575-1077

     More details

    Language:English   Publisher:Life Science Alliance  

    Myocardial mitochondria are primary sites of myocardial energy metabolism. Mitochondrial disorders are associated with various cardiac diseases. We previously showed that mice with cardiomyocyte-specific knockout of the mitochondrial translation factor p32 developed heart failure from dilated cardiomyopathy. Mitochondrial translation defects cause not only mitochondrial dysfunction but also decreased nicotinamide adenine dinucleotide (NAD+) levels, leading to impaired lysosomal acidification and autophagy. In this study, we investigated whether nicotinamide mononucleotide (NMN) administration, which compensates for decreased NAD+ levels, improves heart failure because of mitochondrial dysfunction. NMN administration reduced damaged lysosomes and improved autophagy, thereby reducing heart failure and extending the lifespan in p32cKO mice. We found that lysosomal damage due to mitochondrial dysfunction induced ferroptosis, involving the accumulation of iron in lysosomes and lipid peroxide. The ameliorative effects of NMN supplementation were found to strongly affect lysosomal function rather than mitochondrial function, particularly lysosome-mediated ferroptosis. NMN supplementation can improve lysosomal, rather than mitochondrial, function and prevent chronic heart failure.

    DOI: 10.26508/lsa.202302116

    Web of Science

    Scopus

    PubMed

  • Induction of glioblastoma cell ferroptosis using combined treatment with chloramphenicol and 2-deoxy-d-glucose Invited Reviewed International journal

    Miki, K; Yagi, M; Noguchi, N; Do, Y; Otsuji, R; Kuga, D; Kang, DC; Yoshimoto, K; Uchiumi, T

    SCIENTIFIC REPORTS   13 ( 1 )   10497   2023.6   ISSN:2045-2322

     More details

    Language:Japanese   Publisher:Scientific Reports  

    Glioblastoma, a malignant tumor, has no curative treatment. Recently, mitochondria have been considered a potential target for treating glioblastoma. Previously, we reported that agents initiating mitochondrial dysfunction were effective under glucose-starved conditions. Therefore, this study aimed to develop a mitochondria-targeted treatment to achieve normal glucose conditions. This study used U87MG (U87), U373, and patient-derived stem-like cells as well as chloramphenicol (CAP) and 2-deoxy-d-glucose (2-DG). We investigated whether CAP and 2-DG inhibited the growth of cells under normal and high glucose concentrations. In U87 cells, 2-DG and long-term CAP administration were more effective under normal glucose than high-glucose conditions. In addition, combined CAP and 2-DG treatment was significantly effective under normal glucose concentration in both normal oxygen and hypoxic conditions; this was validated in U373 and patient-derived stem-like cells. 2-DG and CAP acted by influencing iron dynamics; however, deferoxamine inhibited the efficacy of these agents. Thus, ferroptosis could be the underlying mechanism through which 2-DG and CAP act. In conclusion, combined treatment of CAP and 2-DG drastically inhibits cell growth of glioblastoma cell lines even under normal glucose conditions; therefore, this treatment could be effective for glioblastoma patients.

    DOI: 10.1038/s41598-023-37483-5

    Web of Science

    Scopus

    PubMed

    researchmap

  • FOXK1 promotes nonalcoholic fatty liver disease by mediating mTORC1-dependent inhibition of hepatic fatty acid oxidation Reviewed International journal

    Fujinuma, S; Nakatsumi, H; Shimizu, H; Sugiyama, S; Harada, A; Goya, T; Tanaka, M; Kohjima, M; Takahashi, M; Izumi, Y; Yagi, M; Kang, D; Kaneko, M; Shigeta, M; Bamba, T; Ohkawa, Y; Nakayama, KI

    CELL REPORTS   42 ( 5 )   112530   2023.5   ISSN:2211-1247

     More details

    Language:Japanese   Publisher:Cell Reports  

    Nonalcoholic fatty liver disease (NAFLD) is a chronic metabolic disorder caused by overnutrition and can lead to nonalcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC). The transcription factor Forkhead box K1 (FOXK1) is implicated in regulation of lipid metabolism downstream of mechanistic target of rapamycin complex 1 (mTORC1), but its role in NAFLD-NASH pathogenesis is understudied. Here, we show that FOXK1 mediates nutrient-dependent suppression of lipid catabolism in the liver. Hepatocyte-specific deletion of Foxk1 in mice fed a NASH-inducing diet ameliorates not only hepatic steatosis but also associated inflammation, fibrosis, and tumorigenesis, resulting in improved survival. Genome-wide transcriptomic and chromatin immunoprecipitation analyses identify several lipid metabolism-related genes, including Ppara, as direct targets of FOXK1 in the liver. Our results suggest that FOXK1 plays a key role in the regulation of hepatic lipid metabolism and that its inhibition is a promising therapeutic strategy for NAFLD-NASH, as well as for HCC.

    DOI: 10.1016/j.celrep.2023.112530

    Web of Science

    Scopus

    PubMed

    researchmap

  • FOXK1 promotes nonalcoholic fatty liver disease by mediating mTORC1-dependent inhibition of hepatic fatty acid oxidation Reviewed International journal

    Shun Fujinuma, Hirokazu Nakatsumi, Hideyuki Shimizu, Shigeaki Sugiyama, Akihito Harada, Takeshi Goya, Masatake Tanaka, Motoyuki Kohjima, Masatomo Takahashi, Yoshihiro Izumi, Mikako Yagi, Dongchon Kang, Mari Kaneko, Mayo Shigeta, Takeshi Bamba, Yasuyuki Ohkawa, Keiichi I. Nakayama

    Cell Reports   2023.5

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)  

    DOI: doi.org/10.1016/j.celrep.2023.112530

  • Reducing relapse through maintenance steroid treatment can decrease the cancer risk in patients with IgG4-sclerosing cholangitis: Based on a Japanese nationwide study

    Kubota K., Kamisawa T., Nakazawa T., Tanaka A., Naitoh I., Kurita Y., Takikawa H., Unno M., Kawa S., Masamune A., Nakamura S., Okazaki K., Furumatsu K., Sawai S., Goto T., Okumura T., Suzuki D., Otsuka M., Kobori I., Tamano M., Koizumi M., Hiasa Y., Kawabe N., Hirooka Y., Yamamoto S., Asano Y., Inui K., Horiguchi A., Watanabe H., Toya D., Hatayama K., Ueki T., Kinoshita N., Sugimoto M., Ohira H., Mukai T., Tomita E., Iwata K., Shimizu S., Suetsugu J., Shimizu M., Tsuji K., Ishida R., Ito M., Furukawa R., Sakamoto N., Araki M., Tanno S., Sakamoto Y., Ito T., Takai S., Ikeya S., Yamada T., Kudara N., Shimizu A., Hanada K., Ichiki Y., Kitada H., Hifumi M., Kimura H., Kurosaki M., Izumi N., Sumi H., Haruta J.i., Hayashi K., Harada R., Inoue M., Nakamura S., Ito T., Tomishima K., Isayama H., Oura K., Masaki T., Shimokawahara N., Tanoue S., Maemura K., Ido A., Mizushima I., Kawano M., Yoshida K., Naganuma M., Murata M., Nishio A., Fujita Y., Teratani T., Matsubara S., Tamai H., Yoshida Y., Azemoto R., Kamata K., Watanabe T., Kurosu T., Koizumi W., Fujita J., Seki H., Ueda Y., Fukumoto T., Kousaki T., Uchida K., Ochiai T.

    Journal of Gastroenterology and Hepatology (Australia)   38 ( 4 )   556 - 564   2023.4   ISSN:08159319

     More details

    Publisher:Journal of Gastroenterology and Hepatology (Australia)  

    Objective: IgG4-related sclerosing cholangitis (IgG4-SC) is recognized as a benign steroid-responsive disease; however, little is known about the risk of development of cancer in patients with IgG4-SC and about how to counter this risk. Design: We conducted a retrospective review of the data of 924 patients with IgG4-SC selected from a Japanese nationwide survey. The incidence, type of malignancy, and risk of malignancy in these patients were examined. Then, the standardized incidence ratio (SIR) of cancer in patients with IgG4-SC was calculated. Results: Relapse was recognized in 19.7% (182/924) of patients, and cancer development was noted in 15% (139/924) of patients. Multivariate analysis identified only relapse as an independent risk factor for the development of cancer. In most of these patients with pancreato-biliary cancer, the cancer developed within 8 years after the diagnosis of IgG4-SC. The SIR for cancer after the diagnosis of IgG4-SC was 12.68 (95% confidence interval [CI] 6.89–8.79). The SIRs of cancers involving the biliary system and pancreas were 27.35 and 18.43, respectively. The cumulative survival rate was significantly better in the group that received maintenance steroid treatment (MST) than in the group that did not; thus, MST influenced the prognosis of these patients. Conclusion: Among the cancers, the risk of pancreatic and biliary cancers is the highest in these patients. Because of the elevated cancer risk, surveillance after the diagnosis and management to prevent relapse are important in patients with IgG4-SC to reduce the risk of development of cancer.

    DOI: 10.1111/jgh.16066

    Scopus

  • Involvement of Increased Numbers of Dysfunctional Mitochondria and the Accumulation of Fe<sup>2+</sup> in the Enhanced Generation of ROS in Replicative Senescent Human Epidermal Keratinocytes

    Shimoda Nene, Hiramatsu Ayumi, Tsuruta Yoshinobu, Akashika Kaede, Yoshida Moemi, Yoshimoto Satoshi, Yagi Mikako, Matsushima Yuichi, Yagi Masayuki, Ichihashi Masamitsu, Ando Hideya

    JOURNAL OF JAPANESE COSMETIC SCIENCE SOCIETY   47 ( 1 )   6 - 14   2023.3   ISSN:18802532 eISSN:21880719

     More details

    Language:Japanese   Publisher:Japanese Cosmetic Science Society  

    <p>It is well known that the generation of reactive oxygen species (ROS) is increased in aged cells, however, there have been no reports on ROS levels in replicative senescent normal human epidermal keratinocytes (NHEKs). In this study, we investigated the mechanism of increased ROS generation in replicative senescent NHEKs using long-term cultured NHEKs. We defined primary NHEKs cultured for 27 days as aged NHEKs since they express various senescence markers and have decreased proliferation, and compared them with young NHEKs cultured for 13 days that did not show any senescence traits. The number of mitochondria in aged NHEKs increased along with cell enlargement due to aging but the mitochondrial density per protein content was not significantly different from that of young NHEKs. However, the ability to produce ATP was significantly decreased in aged NHEKs compared to young NHEKs. On the other hand, the amount of superoxide that was produced by mitochondria was not significantly different between young and aged NHEKs, and the amount of Mn-SOD (superoxide dismutase), which catalyzes superoxide to hydrogen peroxide, was significantly increased in aged NHEKs compared to young NHEKs. In addition, when hydrogen peroxide was added to the culture medium of young and of aged NHEKs, the scavenging rate was unexpectedly higher in aged NHEKs than in young NHEKs. Furthermore, the amounts of hydroxyl radicals derived from hydrogen peroxide, and Fe<sup>2+</sup>, which catalyzes the reaction, were both higher in aged NHEKs than in young NHEKs. These results suggested that some hydrogen peroxide that had not been eliminated by catalase or glutathione peroxidase is converted to hydroxyl radicals by Fe<sup>2+</sup>, which may contribute to the increased generation of ROS in replicative senescent NHEKs.</p>

    DOI: 10.11469/koshohin.47.6

    CiNii Research

  • 複製老化したヒト表皮角化細胞におけるROS発生の増大にはATP産生能が低下したミトコンドリアの増加とFe2+の蓄積が関与する

    下田 寧々, 平松 歩, 鶴田 純將, 赤鹿 楓, 吉田 萌生, 吉本 聖, 八木 美佳子, 松島 雄一, 八木 政幸, 市橋 正光, 安藤 秀哉

    日本香粧品学会誌   47 ( 1 )   6 - 14   2023.3   ISSN:1880-2532

     More details

    Language:Japanese   Publisher:日本香粧品学会  

    長期継代培養によって複製老化した正常ヒト真皮線維芽細胞(NHEK)を用いてミトコンドリア量や抗酸化力を比較し、複製老化した細胞における活性酸素種(ROS)増大メカニズムを解析した。新生児包皮の表皮から得られた初代培養正常ヒト表皮角化細胞を培養し、培養日数13日間をyoung、27日間をagedとした。細胞内ATP量を測定した。その結果、agedでは同細胞数および同タンパク質量あたりyoungと比較して減少していることから、ミトコンドリア活性がagedで低下していることを示す結果が得られた。ミトコンドリアから発生するスーパーオキシドを過酸化水素に代謝するMn-SODのタンパク質量を検出した。その結果、agedにおいてyoungよりも同細胞数、同タンパク質量あたりMn-SOD量が増加していた。複製老化表皮角化細胞において、一部の過酸化水素が複製老化に伴って増加した二価の鉄イオンによってヒドロキシラジカルに変換され多量のROSが発生していることが示唆された。

  • Mitochondrial and lysosomal crosstalk in aging diseases

    Yagi Mikako, Uchiumi Takeshi

    94 ( 6 )   882 - 887   2022.12   ISSN:00371017

     More details

  • Mitochondrial dysfunction-induced high hCG associated with development of fetal growth restriction and pre-eclampsia with fetal growth restriction International journal

    Kiyokoba Ryo, Uchiumi Takeshi, Yagi Mikako, Toshima Takahiro, Tsukahara Shigehiro, Fujita Yasuyuki, Kato Kiyoko, Kang Dongchon

    Scientific Reports   12 ( 1 )   4056   2022.5   ISSN:2045-2322 eISSN:20452322

     More details

    Language:English  

    Fetal growth restriction (FGR) and pre-eclampsia with fetal growth restriction (PE/FGR) are high-risk perinatal diseases that may involve high levels of human chorionic gonadotropin (hCG) and mitochondrial dysfunction. However, little is known about how these factors affect placental function. We investigated how mitochondrial dysfunction and high hCG expression affected placental function in unexplained FGR and PE/FGR. We observed elevated expression of hCGβ and growth differentiation factor 15 mRNA and protein levels in the placenta with both diseases. Likewise, antiangiogenic factors, such as Ang2, IP10, sFlt1, IL8, IL1B, and TNFα, were also upregulated at the mRNA level. In addition, the expression of COXI and COXII which encoded by mitochondrial DNA were significantly decreased in both diseases, suggesting that mitochondrial translation was impaired. Treatment with hCG increased Ang2, IP10, IL8, and TNFα mRNA levels in a dose-dependent manner via the p38 and JNK pathways. Mitochondrial translation inhibitors increased hCGβ expression through stabilization of HIF1α, and increased IL8 and TNFα mRNA expression. These results revealed that high expression of hCG due to mitochondrial translational dysfunction plays an important role in the pathogenesis of FGR and PE/FGR.

    DOI: 10.1038/s41598-022-07893-y

    Web of Science

    Scopus

    PubMed

    CiNii Research

    researchmap

  • Cancer genomic profiling identified dihydropyrimidine dehydrogenase deficiency in bladder cancer promotes sensitivity to gemcitabine Invited Reviewed International journal

    Shigehiro Tsukahara, Masaki Shiota, Dai Takamatsu, Shohei Nagakawa, Takashi Matsumoto, Ryo Kiyokoba, Mikako Yagi, Daiki Setoyama, Nozomi Noda, Shinya Matsumoto, Tetsutaro Hayashi, Alberto Contreras-Sanz, Peter C. Black, Junichi Inokuchi, Kenichi Kohashi, Yoshinao Oda, Takeshi Uchiumi, Masatoshi Eto, Dongchon Kang

    SCIENTIFIC REPORTS   12 ( 1 )   8535   2022.5   ISSN:2045-2322

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/s41598-022-12528-3

    Web of Science

    Scopus

    PubMed

    researchmap

  • Mitochondrial dysfunction-induced high hCG associated with development of fetal growth restriction and pre-eclampsia with fetal growth restriction Reviewed International journal

    Ryo Kiyokoba, Takeshi Uchiumi, Mikako Yagi, Takahiro Toshima, Shigehiro Tsukahara, Yasuyuki Fujita, Kiyoko Kato, Dongchon Kang

    Scientific reports   2022.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: doi.org/10.1038/s41598-022-07893-y

  • Mitochondrial translation inhibition triggers ATF4 activation, leading to integrated stress response but not to mitochondrial unfolded protein response Invited Reviewed International journal

    Katsuhiko Sasaki, Takeshi Uchiumi, Takahiro Toshima, Mikako Yagi, Yura Do, Haruka Hirai, Ko Igami, Kazuhito Gotoh, Dongchon Kang

    BIOSCIENCE REPORTS   40   2020.11

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)  

  • Mitochondrial Protein Synthesis Is Essential for Terminal Differentiation of CD45– TER119–Erythroid and Lymphoid Progenitors Reviewed International journal

    23 ( 11 )   2020.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Other Link: https://doi.org/10.1016/j.isci.2020.101654

  • Mitochondrial p32/C1qbp Is a Critical Regulator of Dendritic Cell Metabolism and Maturation Reviewed

    Kazuhito Gotoh, Takafumi Morisaki, Daiki Setoyama, Katsuhiko Sasaki, Mikako Yagi, Ko Igami, Soichi Mizuguchi, Takeshi Uchiumi, Yoshinori Fukui, Dongchon Kang

    Cell Reports   25 ( 7 )   1800 - 1815.e4   2018.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.celrep.2018.10.057

  • Doxycycline induces apoptosis via ER stress selectively to cells with a cancer stem cell-like properties Importance of stem cell plasticity Reviewed

    Takashi Matsumoto, Takeshi Uchiumi, Keisuke Monji, Mikako Yagi, Daiki Setoyama, Rie Amamoto, Yuichi Matsushima, Masaki Shiota, Masatoshi Eto, Dongchon Kang

    Oncogenesis   6 ( 11 )   2017.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/s41389-017-0009-3

  • Biallelic C1QBP Mutations Cause Severe Neonatal-, Childhood-, or Later-Onset Cardiomyopathy Associated with Combined Respiratory-Chain Deficiencies Reviewed

    American journal of human genetics   101 ( 4 )   525 - 538   2017.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.ajhg.2017.08.015

  • p32 is Required for Appropriate Interleukin-6 Production Upon LPS Stimulation and Protects Mice from Endotoxin Shock Reviewed

    Katsuhiko Sasaki, Kazuhito Gotoh, Sho Miake, Daiki Setoyama, Mikako Yagi, Ko Igami, Takeshi Uchiumi, Donchon Kang

    EBioMedicine   20   161 - 172   2017.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.ebiom.2017.05.018

  • Melanin pigment interrupts the fluorescence staining of mitochondria in melanocytes Reviewed

    Hideya Ando, Yoshiaki Ohagi, Moemi Yoshida, Satoshi Yoshimoto, Yusuke Higashi, Masayuki Yagi, Keisuke Monji, Mikako Yagi, Takeshi Uchiumi, Dongchon Kang, Masamitsu Ichihashi

    Journal of Dermatological Science   84 ( 3 )   349 - 351   2016.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.jdermsci.2016.08.533

  • The expression of ubiquitous mitochondrial creatine kinase is downregulated as prostate cancer progressionz Reviewed

    Rie Amamoto, Takeshi Uchiumi, Mikako Yagi, Keisuke Monji, Yoo Hyun Song, Yoshinao Oda, Masaki Shiota, Akira Yokomizo, Seiji Naito, Dongchon Kang

    Journal of Cancer   7 ( 1 )   50 - 59   2016.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.7150/jca.13207

  • Serum depletion induced cancer stem cell-like phenotype due to nitric oxide synthesis in oncogenic HRas transformed cells Reviewed

    Keisuke Monji, Takeshi Uchiumi, Saki Hoshizawa, Mikako Yagi, Takashi Matsumoto, Daiki Setoyama, Yuichi Matsushima, Kazuhito Gotoh, Rie Amamoto, Donchon Kang

    Oncotarget   7 ( 46 )   75221 - 75234   2016.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.18632/oncotarget.12117

  • Glycolytic genes are targets of the nuclear receptor Ad4BP/SF-1 Reviewed

    Takashi Baba, Hiroyuki Otake, Tetsuya Sato, Kanako Miyabayashi, Yurina Shishido, Chia Yih Wang, Yuichi Shima, Hiroshi Kimura, Mikako Yagi, Yasuhiro Ishihara, Shinjiro Hino, Hidesato Ogawa, Mitsuyoshi Nakao, Takeshi Yamazaki, Dongchon Kang, Yasuyuki Ohkawa, Mikita Suyama, Bon Chu Chung, Ken Ichirou Morohashi

    Nature communications   5   2014.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/ncomms4634

  • Mutation and functional analysis of ABCC2/multidrug resistance protein 2 in a Japanese patient with Dubin-Johnson syndrome Invited Reviewed International journal

    Takeshi Uchiumi, Hiroyuki Tanamachi, Kajiyo Kuchiwaki, Mitsuharu Kajita, Shinya Matsumoto, Mikako Yagi, Tomotake Kanki, Dongchon Kang

    HEPATOLOGY RESEARCH   43 ( 5 )   569 - 575   2013.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/j.1872-034X.2012.01103.x

  • Dihydro-orotate dehydrogenase is physically associated with the respiratory complex and its loss leads to mitochondrial dysfunction Invited Reviewed International journal

    Jing Xian Fang, Takeshi Uchiumi, Mikako Yagi, Shinya Matsumoto, Rie Amamoto, Shinya Takazaki, Haruyoshi Yamaza, Kazuaki Nonaka, Dongchon Kang

    BIOSCIENCE REPORTS   33   217 - 227   2013.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1042/BSR20120097

  • Protein instability and functional defects caused by mutations of dihydro-orotate dehydrogenase in Miller syndrome patients Invited Reviewed International journal

    Jing Xian Fang, Takeshi Uchiumi, Mikako Yagi, Shinya Matsumoto, Rie Amamoto, Toshiro Saito, Shinya Takazaki, Tomotake Kanki, Haruyoshi Yamaza, Kazuaki Nonaka, Dongchon Kang

    BIOSCIENCE REPORTS   32 ( 6 )   631 - 639   2012.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1042/BSR20120046

  • Localization of mRNAs encoding human mitochondrial oxidative phosphorylation proteins Invited Reviewed International journal

    Shinya Matsumoto, Takeshi Uchiumi, Toshiro Saito, Mikako Yagi, Shinya Takazaki, Tomotake Kanki, Dongchon Kang

    MITOCHONDRION   12 ( 3 )   391 - 398   2012.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.mito.2012.02.004

  • Ribonucleoprotein Y-box-binding protein-1 regulates mitochondrial oxidative phosphorylation (OXPHOS) protein expression after serum stimulation through binding to OXPHOS mRNA Invited Reviewed International journal

    Shinya Matsumoto, Takeshi Uchiumi, Hiroyuki Tanamachi, Toshiro Saito, Mikako Yagi, Shinya Takazaki, Tomotake Kanki, Dongchon Kang

    Biochem J   443 ( 2 )   573 - 584   2012.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1042/BJ20111728

  • Arg 901 in the AE1 C-terminal tail is involved in conformational change but not in substrate binding Invited Reviewed International journal

    Shinya Takazaki, Yoshito Abe, Tomohiro Yamaguchi, Mikako Yagi, Tadashi Ueda, Dongchon Kang, Naotaka Hamasaki

    Biochim Biophys Acta   658 - 665   2012.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.bbamem.2011.11.019

  • ERAL1 is associated with mitochondrial ribosome and elimination of ERAL1 leads to mitochondrial dysfunction and growth retardation Invited Reviewed International journal

    Uchiumi, T., Ohgaki, K., Yagi, M., Aoki, Y., Sakai, A., Matsumoto, S. & Kang, D.,

    NUCLEIC ACIDS RESEARCH   38 ( 16 )   5554 - 5568   2010.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1093/nar/gkq305

  • Mutation of His 834 in human anion exchanger 1 affects substrate binding Invited Reviewed International journal

    Shinya Takazaki, Yoshito Abe, Tomohiro Yamaguchi, Mikako Yagi, Tadashi Ueda, Dongchon Kang, Naotaka Hamasaki

    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES   1798 ( 5 )   903 - 908   2010.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.bbamem.2010.01.019

▼display all

Books

  • ミトコンドリア 疾患治療の新時代

    @八木美佳子、@内海健( Role: Joint author)

    羊土社  2023.3 

     More details

    Responsible for pages:100(734)   Language:Japanese   Book type:General book, introductory book for general audience

  • ミトコンドリア 疾患治療の新時代

    八木美佳子, 内海健( Role: Joint author)

    羊土社  2023.3 

     More details

    Language:Japanese   Book type:General book, introductory book for general audience

    researchmap

  • 生化学 第94巻第6号

    @八木美佳子、@内海健( Role: Joint author)

    日本生化学会  2022.12 

     More details

    Responsible for pages:p882-887   Language:Japanese   Book type:Scholarly book

  • 生化学 第94巻第6号

    八木美佳子, 内海健( Role: Joint author)

    日本生化学会  2022.12 

     More details

    Language:Japanese   Book type:Scholarly book

    researchmap

  • ミトコンドリアダイナミクス 機能研究から疾患・老化まで

    @八木美佳子,@内海健,@康東天( Role: Joint author)

    エヌ・ティー・エス  2021.10 

     More details

    Responsible for pages:第2編ミトコンドリアの臨床応用 第1章ミトコンドリア病 第1節ミトコンドリア病モデルマウスの組織別病態解析とメカニズム解析 213ページ   Language:Japanese   Book type:Scholarly book

Presentations

  • ミトコンドリア翻訳障害による心筋症発症メカニズムとその治療

    @八木美佳子、@内海健、@康東天

    日本ミトコンドリア学会  2023.3 

     More details

    Event date: 2023.3

    Language:Japanese   Presentation type:Symposium, workshop panel (public)  

    Venue:帝京大学   Country:Japan  

  • ミトコンドリア翻訳障害による心筋症発症メカニズムとその治療

    八木美佳子, 内海健, 康東天

    日本ミトコンドリア学会  2023.3 

     More details

    Event date: 2023.3

    Language:Japanese  

    Venue:帝京大学   Country:Japan  

    researchmap

  • ミトコンドリア機能障害による心不全の病態解析と治療戦略 Invited

    @八木美佳子、@内海健、@康東天

    日本生化学会  2022.11 

     More details

    Event date: 2022.11 - 2023.11

    Language:Japanese   Presentation type:Symposium, workshop panel (public)  

    Venue:名古屋国際会議場   Country:Japan  

  • ミトコンドリア機能障害による心不全の病態解析と治療戦略 Invited

    八木美佳子, 内海健, 康東天

    日本生化学会  2022.11 

     More details

    Event date: 2022.11 - 2023.11

    Language:Japanese  

    Venue:名古屋国際会議場   Country:Japan  

    researchmap

  • ミトコンドリアとリソソームの新分子機序

    @八木美佳子、@内海健、@康東天

    日本臨床化学会  2021.11 

     More details

    Event date: 2021.11

    Language:Japanese  

    Venue:福岡国際会議場   Country:Japan  

    老化に伴いミトコンドリア機能が低下することでメタボリックシンドローム、神経変性疾患、心筋症、癌を発症すると考えられている。さらに最近ではオートファジー機能や血中NAD+量低下なども老化に伴う疾患として知られている。そこで我々は、心臓組織ではミトコンドリア機能低下によってNAD+量が減少しオートファジー機構の特にリソソーム機能を抑制することが心疾患に繋がることを見出しその詳細なメカニズムを解明した。心臓組織における解析は、ミトコンドリア翻訳機能障害によってHIF1αによる転写制御機構が変化しNAD+合成量が低下してリソソーム機能が低下したと考えている。更なる詳細なメカニズム解析を培養細胞を用いて行った。
    ミトコンドリア翻訳障害により転写因子HIF1αの発現量が変化しNAD+合成酵素Nmnat3の発現が制御され生体内NAD+合成量を調整することが示唆された。さらにNmnat3によるNAD+合成が細胞質で増加するとリソソーム活性が上昇した。逆にNAD+合成量を阻害剤を用いて減少させるとリソソーム活性が減少することも突き止めた。したがって細胞質でのNAD+合成がリソソーム機能には重要であることが分かった。リソソーム活性にはATPが不可欠であるため、リソソーム膜近傍ではNAD合成とATP産生を行う因子が存在しリソソーム活性を制御しているはずである。我々はその因子が解糖系酵素GAPDHとPGKであることを発見し報告した。この詳細なメカニズム解析が老化に伴う疾患の治療戦略に役立つと考えている。

  • ミトコンドリアを介したNAD+合成系がリソソームを制御する機構

    @八木美佳子、@康東天、@内海健

    日本生化学会  2019.9 

     More details

    Event date: 2020.9

    Language:Japanese   Presentation type:Symposium, workshop panel (public)  

    Venue:横浜   Country:Japan  

    老化に伴う多くの疾患はミトコンドリア機能、オートファジー機能, 血中NAD量低下などが関与すると考えられている。ミトコンドリア機能の特にATP産生能低下、活性酸素の増加による細胞障害が疾患の原因とされてきた。飢餓時の蛋白のリサイクリング、損傷蛋白質の除去を司る生体内維持機構としてオートファジーが重要であるが、このオートファジーも老化に伴う疾患に関与することが示唆されている。また老化に伴いNAD量が減少することが疾患の原因となる報告も多い。そこで我々はミトコンドリア機能低下によってNAD量が減少しオートファジー機構の特にリソソーム機能を抑制することが疾患に繋がることを見出しその詳細なメカニズムを解明した。
    我々が作製したミトコンドリア機能不全マウス(p32cKO)の解析により、心筋特異的ノックアウトマウスは早期に拡張型心筋症を発症し約500日で死亡することがわかった。このノックアウトマウスの心筋では、(1)メタボローム解析よりNAD量が低下することを見出した。(2)細胞質に存在するNAD合成酵素(nmnat2)の発現が低下していた。(3)心筋特異的p32cKOマウスではオートファジー関連因子であるp62の発現亢進やLC3-IIの増加、局在変化を認めた。このことはオートファジー機能低下、特にリソソーム機能低下を伴うことが示唆された。(4)電子顕微鏡像によりミトコンドリア形態異常、及びリソソーム形態異常を認めた。リソソーム機能はリソソーム内の酸性化が重要であり、ATP依存的なv-ATPaseによりリソソーム内は酸性に保たれる。そこで、リソソーム機能に重要なATP産生は、ミトコンドリア機能に依存するNAD合成系と連関する可能性が考えられた。

  • ミトコンドリアを介したリソソーム機能制御のメカニズム Invited

    @八木美佳子、@康東天、@内海健

    日本生化学会  2020.9 

     More details

    Event date: 2020.9

    Language:Japanese   Presentation type:Symposium, workshop panel (public)  

    Country:Japan  

    ミトコンドリアは老化に伴い機能が低下することが知られている。そのため、メタボリックシンドローム、神経変性疾患、心筋症、癌、などを発症すると考えられている。さらに老化に伴う疾患の原因として、オートファジー機能低下、ATP産生能低下、NAD量低下、あるいは活性酸素増加などによる細胞障害が推測されるが、その詳細な分子機構は明らかではない。
    我々はミトコンドリアタンパク質p32の機能解析を行ってきた。p32はミトコンドリアのRNAとリボソームの会合に重要な役割を果たすシャペロンとして機能し、ミトコンドリア翻訳に関与することを見出してきた。さらに様々な臓器特異的p32ノックアウトマウスを作製し、臓器ごとに異なるフェノタイプを報告している。その中でも特に、心臓特異的p32ノックアウトマウス(p32cKO)においてオートファジーに変化を見出したためそのメカニズムについて詳しく解析した。
    このp32cKOは、早期に拡張型心筋症を発症し約500日で死亡した。その死亡原因を突き止めるためにメタボローム解析を行った。するとp32cKO心臓組織においてNAD量が減少していた。最近の研究では老化に伴い生体内のNAD量が減少し、老化関連疾患を引き起こすと考えられている。p32cKOではNAD合成酵素の特にサルベージ経路の酵素発現が低下しており、その経路の酵素であるNmnatは酵素活性も低下していた。さらにオートファジー関連因子の発現量や形態の変化、リソソーム形態異常などが観察された。NAD合成酵素の一つであるNamptを阻害するとリソソーム活性が減少することもわかった。したがって、生体内NAD量とオートファジーの特にリソソーム機能には関連性があること、そしてミトコンドリア機能に依存していることについて報告したい。

  • 糖飢餓におけるferropotosisを介したリソソーム機能障害と防御機構

    三木 健嗣, 八木 美佳子, 康 東天, 國崎 祐哉, 吉本 幸司, 内海 健

    日本生化学会大会プログラム・講演要旨集  2023.10  (公社)日本生化学会

     More details

    Language:Japanese  

  • 乳癌組織のミトコンドリア遺伝子体細胞変異はエネルギー代謝経路を変化させる

    渡邉 健司, 山本 滋, 前田 訓子, 西村 愛代, 諌山 慧士朗, 八木 美佳子, 康 東天, 岡 正朗, 永野 浩昭, 水上 洋一

    日本生化学会大会プログラム・講演要旨集  2023.10  (公社)日本生化学会

     More details

    Language:Japanese  

  • ミトコンドリアがつなぐ多彩な疾患研究最前線 ミトコンドリア機能障害による心不全の病態解析と治療戦略

    八木 美佳子, 内海 健, 康 東天

    日本生化学会大会プログラム・講演要旨集  2022.11  (公社)日本生化学会

     More details

    Language:Japanese  

▼display all

MISC

Academic Activities

  • invited speaker International contribution

    Osaka Mito2023  ( Osaka University Japan ) 2023.3

     More details

    Type:Competition, symposium, etc. 

  • Screening of academic papers

    Role(s): Peer review

    2023

     More details

    Type:Peer review 

    Number of peer-reviewed articles in foreign language journals:1

  • 招待講演

    第5回 細胞動態学セミナー  ( 福岡大学 ) 2022.11

     More details

    Type:Competition, symposium, etc. 

  • シンポジウム応募、開催

    日本生化学会  ( 名古屋国際会議場 ) 2022.11

     More details

    Type:Competition, symposium, etc. 

  • 日本生化学会

    ( 名古屋国際会議場 Japan ) 2022.11

     More details

    Type:Competition, symposium, etc. 

    researchmap

  • シンポジウム発表

    生化学会  2020.9

     More details

    Type:Competition, symposium, etc. 

▼display all

Research Projects

  • Elucidation of new molecular mechanisms of mitochondria-related aging diseases and ferroptosis and their treatment

    Grant number:24K14651  2024 - 2027

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Authorship:Principal investigator  Grant type:Scientific research funding

    CiNii Research

  • 肝臓組織特異的発現遺伝子のサイレント変異で翻訳が停止する新規分子機序

    Grant number:23K18217  2023.6 - 2025.3

    科学研究費助成事業  挑戦的研究(萌芽)

    内海 健, 八木 美佳子

      More details

    Grant type:Scientific research funding

    一塩基置換による単一遺伝子疾患の病態解明は疾患の診断・治療に重要であり、正確な診断が望まれている。しかしアミノ酸変化を伴わない一塩基置換、所謂サイレント変異は表現型に影響がない場合が多いと考えられ、見過ごされる例や病態解明が進んでいない例が多い。サイレント変異では一部tRNAのコドン利用率(Codon usage)の違いにより表現型に影響が出るとの報告があるがその詳細な分子機構は明らかでない。
    申請者は肝臓特異的な発現をする遺伝子でサイレント変異が遺伝子疾患と関連することを世界で初めて見出した。本研究ではサイレント変異が如何に表現型に影響を与えるのか新たな分子機序として以下を証明する。

    CiNii Research

  • Elucidation of the molecular pathogenesis of ageing diseases caused by mitochondrial dysfunction and therapeutic effects of NMN.

    Grant number:23K24794  2022.4 - 2025.3

    Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

      More details

    Grant type:Scientific research funding

    CiNii Research

  • 老化に伴い発症するミトコンドリア関連性疾患の機能解析と予防治療

    2021.7 - 2023.3

      More details

    Authorship:Principal investigator 

  • 老化に伴い発症するミトコンドリア関連性疾患の機能解析と予防治療

    Grant number:21K11678  2021 - 2023

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    八木 美佳子

      More details

    Authorship:Principal investigator  Grant type:Scientific research funding

    本研究は疾患治療・予防治療戦略としてNAD+前駆体であるNMNの効果について検証し、リソソーム機能改善による抗老化作用に対する新規有効性を見出すことが主目的である。NMN添加がリソソーム機能を高め、オートファジー分解促進、ミトコンドリア機能改善、最終的に寿命延長につながるという新規メカニズムを提唱し、病態モデルマウスを用いて科学的に証明していく。さらに、生体内NAD+量を増加させる新たな因子を同定することで、様々な疾患治療に貢献できると考えている。

    CiNii Research

  • ミトコンドリア翻訳障害によりNAD+が減少しリソソーム機能低下を引き起こす

    2020

    英語論文オープンアクセス支援

      More details

    Authorship:Principal investigator  Grant type:On-campus funds, funds, etc.

  • ミトコンドリアがオートファジーを制御する新機構と老化随伴疾患代謝物の探索

    2019.4 - 2021.3

      More details

    Authorship:Principal investigator 

    老化に伴う多くの疾患はミトコンドリア機能、オートファジー機能, 血中NAD量低下が関与すると考えられているがその詳細な分子機構は明らかでない。我々が作成した、ミトコンドリア機能不全マウスの解析から心筋特異的ノックアウトマウスでは拡張型心筋症を早期に呈することを見出し、寿命は約500日に減少することを突き止めた。このマウスの心臓を用いて様々な解析を行った結果、オートファジー機能低下、NAD合成酵素発現量低下、を発見し新たなメカニズムの構築を果たした。

  • ミトコンドリア翻訳機能低下はNAD合成を介してリソソーム機能を制御する

    2019

    2019年度研究活動基礎支援制度「外国語校閲経費支援」

      More details

    Authorship:Principal investigator  Grant type:On-campus funds, funds, etc.

  • ミトコンドリアがオートファジーを制御する新機構と老化随伴疾患代謝物の探索

    Grant number:18K15421  2018 - 2020

    日本学術振興会  科学研究費助成事業  若手研究

      More details

    Authorship:Principal investigator  Grant type:Scientific research funding

  • 大脳白質脳症疾患モデルマウスの病態解析と病因関連代謝物の探索

    Grant number:26860371  2014 - 2016

    科学研究費助成事業  若手研究(B)

      More details

    Authorship:Principal investigator  Grant type:Scientific research funding

▼display all

Class subject

  • 生化検査学

    2024.6 - 2024.8   Summer quarter

  • 遺伝子検査学および実習

    2024.4 - 2024.9   First semester

  • 生化学

    2024.4 - 2024.6   Spring quarter

  • 生化学・臨床化学実習

    2023.10 - 2024.3   Second semester

  • 生化学・臨床化学実習

    2023.10 - 2024.3   Second semester

  • 臨床免疫学および実習

    2023.10 - 2024.3   Second semester

  • 臨床免疫学および実習

    2023.10 - 2024.3   Second semester

  • 臨床検査学概論Ⅱ

    2023.10 - 2023.12   Fall quarter

  • 臨床検査学概論Ⅱ

    2023.10 - 2023.12   Fall quarter

  • 臨床検査統計学および演習

    2023.10 - 2023.12   Fall quarter

  • 臨床検査統計学および演習

    2023.10 - 2023.12   Fall quarter

  • 生化検査学

    2023.6 - 2023.8   Summer quarter

  • 生化検査学

    2023.6 - 2023.8   Summer quarter

  • 遺伝子検査学実験

    2023.6 - 2023.8   Summer quarter

  • 遺伝子検査学実験

    2023.6 - 2023.8   Summer quarter

  • 遺伝子検査学および実習

    2023.4 - 2023.9   First semester

  • 遺伝子検査学および実習

    2023.4 - 2023.9   First semester

  • 生化学

    2023.4 - 2023.6   Spring quarter

  • 生化学

    2023.4 - 2023.6   Spring quarter

  • 臨床検査学概論Ⅰ

    2023.4 - 2023.6   Spring quarter

  • 臨床検査学概論Ⅰ

    2023.4 - 2023.6   Spring quarter

  • 臨床免疫学および実習

    2022.10 - 2023.3   Second semester

  • 生化学・臨床化学実習

    2022.10 - 2023.3   Second semester

  • 遺伝子検査学実験

    2022.6 - 2022.8   Summer quarter

  • 臨床検査学概論Ⅰ

    2022.4 - 2022.6   Spring quarter

  • 生化学・臨床化学実習

    2021.10 - 2022.3   Second semester

  • 臨床免疫学および実習

    2021.10 - 2022.3   Second semester

  • 生体情報計測学実験

    2021.10 - 2021.12   Fall quarter

  • 遺伝子検査学実験

    2021.6 - 2021.8   Summer quarter

  • 臨床検査学概論Ⅰ

    2021.4 - 2021.6   Spring quarter

  • 臨床検査学概論Ⅱ

    2020.12 - 2021.2   Winter quarter

  • 生化学・臨床化学実習

    2020.10 - 2021.3   Second semester

  • 臨床免疫学および実習

    2020.10 - 2021.3   Second semester

  • 臨床検査学概論Ⅰ

    2020.10 - 2020.12   Fall quarter

  • 遺伝子検査学実験

    2020.10 - 2020.12   Fall quarter

  • 国際感染症学および実習

    2020.4 - 2020.9   First semester

  • 血液検査学実習

    2020.4 - 2020.9   First semester

  • 臨床微生物学および実習

    2020.4 - 2020.9   First semester

  • 国際感染症学および実習

    2020.4 - 2020.9   First semester

  • 血液検査学実習

    2020.4 - 2020.9   First semester

  • 臨床微生物学および実習

    2020.4 - 2020.9   First semester

  • 生体情報計測学実験

    2019.12 - 2020.2   Winter quarter

  • 生体情報計測学実験

    2019.12 - 2020.2   Winter quarter

  • 臨床免疫学および実習

    2019.10 - 2020.3   Second semester

  • 臨床免疫学および実習

    2019.10 - 2020.3   Second semester

  • 遺伝子検査学実験

    2019.10 - 2019.12   Fall quarter

  • 医用工学・情報概論実験

    2019.10 - 2019.12   Fall quarter

  • 遺伝子検査学実験

    2019.10 - 2019.12   Fall quarter

  • 医用工学・情報概論実験

    2019.10 - 2019.12   Fall quarter

▼display all

FD Participation

  • 2020.9   Role:Participation   Title:遠隔授業の現状を踏まえた今後の活用に向けて!

    Organizer:[Undergraduate school/graduate school/graduate faculty]

Visiting, concurrent, or part-time lecturers at other universities, institutions, etc.

  • 2024  純真学園大学  Classification:Part-time lecturer  Domestic/International Classification:Japan 

  • 2023  純真学園大学  Classification:Part-time lecturer  Domestic/International Classification:Japan 

  • 2022  純真学園大学  Classification:Part-time lecturer  Domestic/International Classification:Japan 

  • 2021  純真学園大学  Classification:Part-time lecturer  Domestic/International Classification:Japan 

Other educational activity and Special note

  • 2023  Class Teacher